Stage 1: Referral information is reviewed to consider clinical scope, consent and current availability. Stage 2: A clinical assessment may use appropriate validated measures, such as PHQ 9, GAD 7 or PCL 5. Stage 3: Any therapy and treating clinician documentation are agreed individually, including the scope and timing of any report.